NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹105.33 | ₹77.56 | ₹39.19 | ₹9.32 | ₹24.16 |
What is the latest Earnings Per Share (EPS) of NATCO PHARMA ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹105.33 |
| Mar2024 | ₹77.56 |
| Mar2023 | ₹39.19 |
| Mar2022 | ₹9.32 |
| Mar2021 | ₹24.16 |
How is Earnings Per Share (EPS) of NATCO PHARMA Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹105.33 | 35.80 | |
| Mar2024 | ₹77.56 | 97.91 | |
| Mar2023 | ₹39.19 | 320.49 | |
| Mar2022 | ₹9.32 | -61.42 | |
| Mar2021 | ₹24.16 | - | |
Compare Earnings Per Share (EPS) of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,973.9 Cr | -2% | -1.5% | -29.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,019.0 Cr | -3.5% | -5.4% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,752.0 Cr | -3.6% | 0.2% | 11.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,542.0 Cr | -0.5% | 5.9% | 20.3% | Stock Analytics | |
| CIPLA | ₹115,883.0 Cr | -1.8% | -4.8% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,024.7 Cr | -1.7% | -7.3% | -12.1% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -2% |
-1.5% |
-29.6% |
| SENSEX | -1.9% |
-2.2% |
7.4% |
You may also like the below Video Courses